Biotech Values

[kei]

XXII imo only but there is a possibility that TAKEDA might be interested in $XXII based on the pr yesterday (asian market)

http://www.businesswire.com/news/home/20170606005106/en/22nd-Century-Produces-Non-GMO-Nicotine-Tobacco

please read the balded part:

In the United States, federal regulation will not treat the new Very Low Nicotine tobacco varieties as “genetically modified;” further, these new proprietary tobacco strains will not be subject to burdensome regulation and import restrictions in most countries around the world. Representing a major improvement on the Company’s already successful Very Low Nicotine tobacco, the new proprietary varieties hold immense promise to open up large international markets for the Company. 22nd Century is already in contact with marketers and distributors in countries with GMO restrictions (Japan, India, and Korea) to facilitate the import of products based on the Company’s new non-GMO Very Low Nicotine tobaccos.